{
  "16959552-DS-18": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nDiarrhea\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nThis is a ___ year old woman with a PMH of HFpEF, OSA/OHS on home\no2/bipap, IDDM, HTN, HLD, relapsing polychondritis, Gastric Ca\ns/p abdominal surgery at ___ ___ ago, who presents from ___\nnursing facility with 2 days of loose stool and acute renal\nfailure. She had diarrhea all night on ___, which she \nreports\nwas brown, but with some blood on the tissue paper after wiping.\nShe denies frank BRBPR or hematemesis. She also reports left\nsided abdominal pain over the past day, mild in intensity,\nnon-radiating.  She denies fever, chills, SOB, CP. She has a \nmild\nheadache. She denies dysuria or urinary frequency. She reports\nchronic low back pain.\n\nIn the ED:\n\nInitial vital signs were notable for:  \nT 98.0 HR 66 BP 105/43 RR 18 SpO2 98% RA \n\nExam notable for:\n-BP 105/43\n-CV RRR\n-CTAB\n-Abd: mildly TTP in LUQ and LLQ\n-No CVAT\n-Mild peripheral edema\n\nLabs were notable for:\n- WBC 5.4\n- HG 10.8\n- K 5.9\n- Cr 4.9 \n- INR 1.1\n- lactate 1.9\n- proBNP 2855\n\n- Urine lytes:\n  - UreaN:364 \n  - Creat:128 \n  - Na:23 \n  - Osmolal:311\n\n- UA\n  - Mod leuk\n  - 11 WBC\n  - Few bacteria \n  - 30 prot\n\nStudies performed include:\n+ CT A/P: \n1. Small bowel obstruction with fecalized small bowel contents\nleading to a transition point in the low anterior abdomen. No\nfree fluid or pneumoperitoneum. \n2. No diverticulitis, fluid collection, or hydronephrosis.\n\nPatient was given:\n-Insulin (Regular) for Hyperkalemia 10 units\n-Dextrose 50% 25 gm\n-Calcium Gluconate \n-D5NS \n-NS 500 mL\n-Lidocaine 5% Patch\n-Tiotropium Bromide 1 CAP\n-Heparin gtt 1450 units/hr \n-Insulin 2 Units\n-Acetaminophen IV 1000 mg\n-Gastroview (Diatrizoate Meglumine & Sodium) 30 mL\n\nConsults:\n- Surgery: \"Patient denies any symptoms consistent with acute\nsmall bowel obstruction. It is possible that findings on CT are\nrelatively chronic. Recommend medical admission for acute on\nchronic renal failure, with increasing SOB. ACS will follow and\nwill recommend gastrograffin contrast study tomorrow to evaluate\npassage of contrast through small bowel to the level of the\ncolon. Please keep NPO for now. No need for NGT if not \nvomiting.\"\n\n- Renal: \"Patient has some amount of CKD with a baseline Cr of\n~1.5-1.6. Now has SBO per CT result with several days of nausea \n,\nvomiting and poor PO intake. This is in the setting of\nhypotension and exposure to several medications and ACEI -\nlisinopril. This has all likely contributed to ___ worsening\nrenal failure along with a component of cardiorenal syndrome\nwhich is likely chronic. She is NPO per surgery. \n- Please stop lisinopril and hold BP meds given hypotension. \n- Ensure that she is not hypovolemic. \n- No hydronephrosis on CT scan. \n- Check PVR and ensure no retention  \n- Be sure to dose medications renally (specifically medications\nwhich are sedating like gabapentin). \n- Please send UA and urine culture to ensure no UTI is present. \n- Monitor I/O. \n- Please consult us as inpatient if further recommendations of\nworkup is needed. \n- Agree with workup of underlying cause of nausea and vomiting\nper surgery and medicine ( SBO seen on CT).\"\n\nVitals on transfer: T 98.0 HR 67 BP 142/99 RR 18 SpO2 92% 2L NC \n\nUpon arrival to the floor, patient is in no acute distress. She\nis wearing sunglasses, and reports that it's because ___ eyes \nare\nbothering ___ from a prior ___ \"eye surgery\". She denies\nabdominal pain. She reports that she has been passing gas.   \n\n \nPast Medical History:\n# Diastolic heart failure (LVEF 55-60%)\n# Atrial flutter (diagnosed ___\n# Pulmonary hypertension\n# OSA and OHS on BiPAP and home O2\n# Asthma/COPD\n# Left-sided stroke in ___ w/ residual left sided weakness\n# IDDM\n# CKD (stage II)\n# Hypertension\n# Dyslipidemia\n# Gastric Ca s/p abdominal surgery at ___ ___ ago\n# Cervical cancer\n# Toe amputations\n \nSocial History:\n___\nFamily History:\nFather deceased with history of throat cancer. Aunt with DM.\nNo family history of early MI, arrhythmia, cardiomyopathies, or \nsudden cardiac death.\n\n \nPhysical Exam:\nADMISSION:\n==========\nVITALS: T 98.3 BP 152 / 68 HR 67 RR 18 SpO2 96% 2L \nGENERAL: Alert and interactive. In no acute distress.\nHEENT: NCAT. PERRL, EOMI. Sclera anicteric and without \ninjection.\nMMM. No JVD.\nCARDIAC: Distant heart sounds, but RRR. Audible S1 and S2. No\nmurmurs/rubs/gallops.\nLUNGS:  Distant breath sounds, scattered expiratory wheezes.  No\nincreased work of breathing on 2L NC.\nBACK: No spinous process tenderness. No CVA tenderness.\nABDOMEN: Hypoactive bowel sounds, obese, mildly distended, \ntender\nto deep palpation of LLQ. Not tympanic. No organomegaly.\nEXTREMITIES: S/p amputation of left ___ toe, with scar from skin\ngraft on dorsum of foot/ankle. No clubbing, cyanosis. \nNon-pitting\nedema of the lower extremities. Pulses DP/Radial 2+ bilaterally.\nSKIN: Warm. Cap refill <2s. No rash.\nNEUROLOGIC: CN2-12 intact. Strength slightly diminished on left\nupper/lower extremity (baseline per patient s/p CVA). Normal\nsensation throughout. AOx3.\n\nDISCHARGE:\n===========\nVITALS: \n24 HR Data (last updated ___ @ 1527)\n    Temp: 98.3 (Tm 98.9), BP: 157/74 (157-168/66-77), HR: 67\n(67-76), RR: 18 (___), O2 sat: 96% (92-96), O2 delivery: 2L,\nWt: 226.19 lb/102.6 kg  \nGeneral: Obese, elderly woman in no acute distress. \nHEENT: PERRL. MMM.\nCardiac: RRR, S1+S2, no M/R/G\nPulmonary: faint bibasilar crackles, occasional scattered\nend-expiratory wheezes. \nAbdomen: non-distended, soft, non-tender\nEXTREMITIES: S/p amputation of left ___ toe, with scar from skin\ngraft on dorsum of foot/ankle. No clubbing, cyanosis. \nNon-pitting\nedema of the lower extremities. Pulses DP/Radial 2+ bilaterally.\nNEUROLOGIC: Alert, moving all 4 extremities with purpose.\nSkin: Skin type V. No gross lesions or eruptions. \n\n \nPertinent Results:\nADMISSION:\n==========\n___ 06:11PM BLOOD WBC-5.4 RBC-4.84 Hgb-10.8* Hct-39.3 \nMCV-81* MCH-22.3* MCHC-27.5* RDW-17.7* RDWSD-51.4* Plt ___\n___ 06:11PM BLOOD Neuts-58.2 ___ Monos-12.1 Eos-3.2 \nBaso-0.4 Im ___ AbsNeut-3.13 AbsLymp-1.37 AbsMono-0.65 \nAbsEos-0.17 AbsBaso-0.02\n___ 04:27PM BLOOD ___ PTT-62.9* ___\n___ 06:11PM BLOOD Glucose-161* UreaN-55* Creat-4.9*# Na-139 \nK-5.9* Cl-100 HCO3-26 AnGap-13\n___ 06:11PM BLOOD ALT-10 AST-8 AlkPhos-64 TotBili-0.2\n___ 06:11PM BLOOD Lipase-50\n___ 11:10PM BLOOD proBNP-___*\n___ 06:20AM BLOOD TotProt-5.8* Calcium-8.4 Phos-5.5* Mg-1.7\n___ 08:07PM BLOOD Lactate-1.9 K-9.5*\n\nIMAGING:\n=========\nKUB ___\nColon remains opacified with contrast material.\n\nKUB ___\nEnteric contrast material is seen throughout the colon.  No \nabnormally dilated \nloops of small or large bowel visualized. \n\nCT A/P ___. Mildly dilated loop of small bowel in the lower abdomen \ncontaining \nfecalized content, with relative caliber change distally, with \nthe more distal \nileum collapsed.  However, the majority of the more proximal \nsmall bowel is \nnot dilated.  Findings are nonspecific, but a very early small \nbowel \nobstruction is not entirely excluded.  Moderate colonic fecal \nloading \nthroughout.  No free fluid or free air. \n2. No diverticulitis, fluid collection, or hydronephrosis. \n\nINTERVAL LABS:\n\n___ 05:10AM BLOOD FreeKap-83.7* FreeLam-35.0* Fr K/L-2.39*\n\nDISCHARGE:\n===========\n___ 05:30AM BLOOD WBC-5.6 RBC-4.27 Hgb-9.4* Hct-33.2* \nMCV-78* MCH-22.0* MCHC-28.3* RDW-18.2* RDWSD-50.2* Plt ___\n___ 05:30AM BLOOD ___ PTT-33.1 ___\n___ 05:30AM BLOOD Glucose-175* UreaN-16 Creat-2.2* Na-143 \nK-4.6 Cl-100 HCO3-30 AnGap-13\n___ 05:30AM BLOOD Calcium-9.5 Phos-4.2 Mg-1.5*\n \nBrief Hospital Course:\nPATIENT SUMMARY FOR ADMISSION:\n==============================\nMs. ___ is a ___ w/ HFpEF (EF 65% ___, atrial \nfibrillation/flutter on apixaban, HTN, HLD, previous CVA, DM \n(A1C 8.6% ___, OSA on CPAP & home O2, mixed \nrestrictive-obstructive lung disease (PFTs ___, previous \nCVA, CKD III, relapsing polychondritis on immunosuppression, & \nhistory of gastric cancer s/p abdominal surgery (@ ___ ___ years \nago) & cervical cancer, who presents w/ diarrhea & ___ on CKD. \n\nISSUES ADDRESSED:\n=================\n# ___ on CKD:\nPresented with Cr 4.9 on admission from baseline above ___ \nbaseline of ~1.1. FEurea 24.7%, Urine Na 23, BUN/Cr 11.4, Urine \nOSM 311. This gives a mixed picture but w/ the clinical picture \nwas mostly suggestive of pre-renal etiology in the setting of \ncopious diarrhea, diuretic use (torsemide), & anti-HTN therapy \nw/ lisinopril. Obstructive causes r/o on CT w/ no evidence of \nhydronephrosis or pelvic masses. Intrinsic etiologies were \ndifficult to definitively r/o but UA was bland on microscoping \nevaluation. The patient in no urgent indications for \nhemodialysis. She was hydrated and renal function very gradually \ndowntrended to 2.2 on discharge. \n\n# Essential HTN:\nHeld home amlodipine & lisinopril in setting of pre-renal ___ \nwith the goal of permissive HTN given renal injury (SBP \n130-160). Amlodipine restarted, then home metop changed to \nlabetalol for better BP control. Lisinopril held.\n\n# Abdominal pain:\n# ?SBO:\nACS consulted, CT was initially concerning for small bowel \nobstruction however on further read no obstruction was noted. \nShe had a normal Gastrografin study and diet was advanced. \n\n#Diarrhea:\nResolved. C. difficile & Norovirus negative. \n\n# HFpEF:\nGrade II diastolic dysfunction, EF 65% on TTE (___). Home \ntoremide held on admission given ___. \n\n# Relapsing polychondritis:\nFollowed by ___ Rheumatology. We continued azathioprine 100mg \nQD (prednisone taper ended ___ + azithromycin QWeek. \n\n# Diabetes mellitus:\nA1C 8.6% ___. Continued 70/30 insulin and held metformin. \nHeld gabapentin given ___. \n\n# Mixed restrictive-obstructive lung disease:\nOn home O2. Supplemental O2. Continued home tiotropium + \nalbuterol PRN. \n\n# Atrial fibrillation/flutter:\n-Rhythm: No AADs.\n-Rate: On metoprolol, initially held to allow for permissive \nhypertension, then changed to labetalol as patient was \nhypertensive\n-AC: On apixaban at home, placed on heparin drip on admission in \nthe setting of possible need for surgical intervention and ___, \nrestarted when GFR was > 30. \n\n# HLD:\nContinued home atorvastatin. \n\nTRANSITIONAL ISSUES:\n====================\nIt was recommended that Ms. ___ go to rehab to get stronger \nand to help with ___ changed medication regimen. Despite \nmultiple discussions with the patient, she refused to go to \nrehab. She was aware of the risks of going home including the \nneed to adjust ___ medication regimen from prior and the risk of \nfalling. To help with safe discharge planning, we set up a home \nvisit for day after discharge with ___ NP. ___ will \ndeliver all of ___ medications and she was instructed to \ncarefully follow ___ NEW med list. \n\nWeight at discharge 102.6 kg / 226.19 lbs. \nCreatinine at discharge: 2.2 \n\n[] Changed meds:\n- Held lisinopril given renal impairment\n- Started labetalol 400 mg BID and held metoprolol (as patient \nwas hypertensive and needed more BP control)\n- Held metformin given renal impairment\n- Held home torsemide given renal impairment. Please restart as \nan outpatient if patient appears volume overloaded. Weight at \ndischarge 102.6 kg / 226.19 lbs. \n[] Insulin: ___ insulin requirements were lower while inpatient \nthan prior. Home 70/30 insulin decreased to 20 U BID on \ndischarge; please re-uptitrate if having elevated blood sugars.\n[] Please recheck chemistry panel within the next ___ days. ___ \nNP will be visiting ___ at home within 1 day of discharge. If \n___ GFR goes below 30 on recheck, will need to hold apixiban. \n[] Patient has renal follow up scheduled ___. \n[] Patient had elevated kappa/lambda ratio while inaptient which \ncould be explained by ___ renal impairment. This should be \nrepeated as an outpatient. \n\nCODE: FULL\nCONTACT: ___ (spiritual sister/advisor) ___, \n___\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Apixaban 5 mg PO BID \n2. Atorvastatin 40 mg PO QPM \n3. AzaTHIOprine 100 mg PO DAILY \n4. Azithromycin 500 mg PO 1X/WEEK (___) \n5. Cyanocobalamin 100 mcg PO DAILY \n6. Docusate Sodium 100 mg PO BID \n7. FoLIC Acid 1 mg PO DAILY \n8. Lisinopril 40 mg PO QHS \n9. Senna 17.2 mg PO QHS:PRN constipation \n10. Tiotropium Bromide 1 CAP IH DAILY \n11. Torsemide 60 mg PO DAILY \n12. Vitamin D 1000 UNIT PO DAILY \n13. Metoprolol Succinate XL 200 mg PO DAILY \n14. Gabapentin 100 mg PO QHS \n15. Moxifloxacin 0.5 % ophthalmic (eye) QID \n16. Lidocaine-Prilocaine 1 Appl TP BID hip \n17. Ascorbic Acid ___ mg PO DAILY \n18. Erythromycin 0.5% Ophth Oint 0.5 in BOTH EYES QID \n19. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheeze \n20. Ipratropium-Albuterol Neb 1 NEB NEB Q6H \n21. Acetaminophen 325 mg PO Q4H:PRN Pain - Mild \n22. PredniSONE 2 mg PO DAILY \n23. Glucagon 1 mg Subcut Q15MIN:PRN hypoglycemia \n24. OxyCODONE--Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain - \nModerate \n25. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing \n26. NovoLOG Mix ___ U-100 (insulin asp prt-insulin \naspart) 50  subcutaneous BID \n27. MetFORMIN (Glucophage) 1000 mg PO QAM \n28. MetFORMIN (Glucophage) 1500 mg PO QPM \n\n \nDischarge Medications:\n1.  amLODIPine 10 mg PO DAILY \nRX *amlodipine 10 mg 1 tablet(s) by mouth once a day Disp #*30 \nTablet Refills:*0 \n2.  Labetalol 400 mg PO BID \nRX *labetalol 200 mg 2 tablet(s) by mouth twice a day Disp #*120 \nTablet Refills:*0 \n3.  NovoLOG Mix 70-30 U-100 Insuln (insulin asp prt-insulin \naspart) 20 U subcutaneous BID \nRX *insulin asp prt-insulin aspart [Novolog Mix ___ \nU-100] 100 unit/mL (70-30) 20 U subcutaneous twice a day Disp \n#*3 Syringe Refills:*0 \n4.  Acetaminophen 325 mg PO Q4H:PRN Pain - Mild  \n5.  Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheeze  \n6.  Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing \nRX *albuterol sulfate [ProAir HFA] 90 mcg 2 puff inhaled every \nsix (6) hours Disp #*1 Inhaler Refills:*0 \n7.  Apixaban 5 mg PO BID  \n8.  Ascorbic Acid ___ mg PO DAILY  \n9.  Atorvastatin 40 mg PO QPM  \n10.  AzaTHIOprine 100 mg PO DAILY \nRX *azathioprine [Azasan] 100 mg 1 tablet(s) by mouth once a day \nDisp #*30 Tablet Refills:*0 \n11.  Azithromycin 500 mg PO 1X/WEEK (___)  \n12.  Cyanocobalamin 100 mcg PO DAILY  \n13.  Docusate Sodium 100 mg PO BID  \n14.  Erythromycin 0.5% Ophth Oint 0.5 in BOTH EYES QID \nRX *erythromycin 5 mg/gram (0.5 %) 0.5 (One half) cm in each eye \nfour times a day Refills:*0 \n15.  FoLIC Acid 1 mg PO DAILY  \n16.  Gabapentin 100 mg PO QHS \nRX *gabapentin 100 mg 1 capsule(s) by mouth at bedtime Disp #*30 \nCapsule Refills:*0 \n17.  Glucagon 1 mg Subcut Q15MIN:PRN hypoglycemia  \n18.  Ipratropium-Albuterol Neb 1 NEB NEB Q6H \nRX *ipratropium-albuterol 0.5 mg-3 mg (2.5 mg base)/3 mL 3 mL \ninhaled every six (6) hours Disp #*10 Ampule Refills:*0 \n19.  Lidocaine-Prilocaine 1 Appl TP BID hip  \n20.  Moxifloxacin 0.5 % ophthalmic (eye) QID \nRX *moxifloxacin 0.5 % 1 drop in the left eye four times a day \nRefills:*0 \n21.  Senna 17.2 mg PO QHS:PRN constipation \nRX *sennosides [senna] 8.6 mg 2 tablets by mouth at bedtime Disp \n#*60 Tablet Refills:*0 \n22.  Tiotropium Bromide 1 CAP IH DAILY  \n23.  Vitamin D 1000 UNIT PO DAILY \nRX *ergocalciferol (vitamin D2) 2,000 unit 0.5 (One half) tablet \nby mouth once a day Disp #*30 Tablet Refills:*0 \n24. HELD- Lisinopril 40 mg PO QHS  This medication was held. Do \nnot restart Lisinopril until your kidney function is better\n25. HELD- MetFORMIN (Glucophage) 1000 mg PO QAM  This medication \nwas held. Do not restart MetFORMIN (Glucophage) until kidney \nfunction improves\n26. HELD- MetFORMIN (Glucophage) 1500 mg PO QPM  This medication \nwas held. Do not restart MetFORMIN (Glucophage) until kidney \nfunction improves\n27. HELD- MetFORMIN (Glucophage) 1500 mg PO QPM  This medication \nwas held. Do not restart MetFORMIN (Glucophage) until you speak \nwith your PCP\n28. HELD- Torsemide 60 mg PO DAILY  This medication was held. Do \nnot restart Torsemide until told to do so by your doctor\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY:\nacute kidney injury \ndiarrhea\n\nSECONDARY:\nHeart failure with preserved ejection fraction\nRelapsing polychondritis\nDiabetes \nHypertension\nHyperlipidemia\nAtrial fibrillation\nMixed restrictiveobstructive lung disease\nObstructive sleep apnea\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking care of you at ___.\n\nWHY WERE YOU ADMITTED?\n-You are having diarrhea and your kidneys were not working as \ngood as they should.\n\nWHAT HAPPENED WHEN YOU WERE HERE?\n-We gave you fluids to help hydrate your kidney and your kidney \nfunction improved but is still not back to normal. This will be \nclosely monitored as an outpatient. \n-We tested you for 2 infections that can cause diarrhea and \nthere was no evidence of infection. \n-There were some concerns initially that you had a bowel \nobstruction, but we did studies that showed that you did not \nhave this.  \n\nWHAT SHOULD YOU DO WHEN YOU GO HOME?\n-Continue take all of your medications as prescribed.\n-Go to all of your appointments.  Please do not hesitate to \nreturn to the hospital\n-Continues take all of your medications as prescribed if you \nhave any symptoms that concern you. \nWe wish you the best!\n\nSincerely,\nYour ___ Medicine Team\n \nFollowup Instructions:\n___\n"
}